title: Synthesis, pharmacokinetics, and pharmacodynamics studies of valsartan peptide derivatives.
abstract: In order to increase the intestinal permeability of valsartan, 14 esters and peptide derivatives of valsartan were chemically synthesized and their absorption characteristics were described. All derivatives were stable and could be better absorbed into the small intestine than valsartan. There are two barriers for the absorption of valsartan derivatives. The elongated half-life (t(1/2)) and stable blood concentrations for compound 4 due to the hydrolysis of the ester group in the second barrier were demonstrated in pharmacokinetic experiments. Furthermore, compound 4 also displayed modest anti-hypertension activity in vivo, which makes structural modification of valsartan, especially for the purpose of improvement of its intestinal permeability, valuable for further studies.
authors.affiliation: Chemistry Section, Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, China.
authors.forename: Chun
authors.initials: C
authors.lastname: Wu
authors.forename: Yanpeng
authors.initials: Y
authors.lastname: Hu
authors.forename: Qianbin
authors.initials: Q
authors.lastname: Li
authors.forename: Limei
authors.initials: L
authors.lastname: He
authors.forename: Jun
authors.initials: J
authors.lastname: Chen
authors.forename: Zeneng
authors.initials: Z
authors.lastname: Cheng
authors.forename: Yuanjian
authors.initials: Y
authors.lastname: Li
authors.forename: Gaoyun
authors.initials: G
authors.lastname: Hu
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000138:chemical synthesis*; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D004355:Drug Stability; D005260:Female; D007408:Intestinal Absorption; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D013777:Tetrazoles / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology; D014633:Valine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000493:pharmacokinetics / Q000494:pharmacology; D000068756:Valsartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine